TRASIS nominated as a finalist of the prestigious ‘Promising Company of the Year’ award !
For the sixth year, EY, in collaboration with BNP Paribas Fortis and l’Echo, has organised the ‘Promising Company of the Year’ competition for the 6th time in Wallonia.
This award is open to growing start-ups that have demonstrated exceptional capability in terms of innovation, entrepreneurship, strategy, global awareness and determination.
Trasis naturally decided to take part.
Trasis has striven since 2004 to provide the best solutions for the synthesis, conditioning and administration of radiopharmaceutical substances which enable more effective medical diagnostics to be carried out, particularly in oncology. Over the years it has become a key player in the field.
Today, we were pleased and proud to learn that our company TRASIS has been nominated as a finalist for the "Promising Company of the Year 2017” award.
This nomination confirms Trasis in its current directions, and will, without doubt, provide further motivation for it remaining true to the spirit of creativity, commitment to its customers and in-house harmony which have guided it until now.
Trasis would also like to take this opportunity to thank its team, its local and regional public partners, its customers and its suppliers, who have contributed to being selected.